Senior Manager, Downstream, Manufacturing Science and Technology (MSAT) at Charles River
Kevin has been in the manufacturing and technology transfer space for the last 13 years, with the first half of his career spent in large scale production of monoclonal antibodies (mABs) and the latter focussed on the contract development and manufacturing of viral vectors for cell and gene therapies. Kevin has spent the last five years at Charles River’s Maryland-based viral vector CDMO center of excellence specializing in the downstream (purification) aspects of viral vector technology transfer.
Serving as subject matter experts on client projects for cross-functional teams including QA, QC, facilities, and business development, Kevin and his team are responsible for transferring a fully developed downstream purification process from a client, or process development, to GMP.
Kevin graduated from the University of St. Joseph (USJ) with a master's degree in Biochemistry in 2016, preceded by a bachelor's degree in biochemistry from the University of Maryland Baltimore County (UMBC) in 2011.